BJRI insider plans sale of 21,704 shares

Gregory Lynds filed to sell up to 21,704 shares of common stock of BJRI through Morgan Stanley Smith Barney LLC Executive Financial Services, with a proposed sale date of 08/06/2026 on NASDAQ.

Rhea-AI Filing Summary

Gregory Lynds filed to sell up to 21,704 shares of common stock of BJRI through Morgan Stanley Smith Barney LLC Executive Financial Services, with a proposed sale date of 08/06/2026 on NASDAQ. The shares to be sold include 17,674 restricted stock shares granted on 01/02/2012 and 4,030 performance shares granted on 02/20/2019. Over the past three months, Lynds has reported additional common stock sales, including 25,350 shares on 08/03/2026, 6,201 shares on 06/18/2026, and 5,537 shares on 06/11/2026.

Key Figures

Planned shares to be sold: 21,704 shares Estimated value of planned sale: $1,493,348.06 Restricted stock grant: 17,674 shares +4 more

7 metrics

Planned shares to be sold 21,704 shares Common stock proposed for sale with date 08/06/2026

Estimated value of planned sale $1,493,348.06 Associated with 21,704 common shares to be sold

Restricted stock grant 17,674 shares Restricted Stock granted on 01/02/2012, identified as source of shares

Performance shares grant 4,030 shares Performance Shares granted on 02/20/2019, identified as source of shares

Sale on 08/03/2026 25,350 shares for $1,710,470.97 Common stock sold by Gregory Lynds during past 3 months

Sale on 06/18/2026 6,201 shares for $346,413.28 Common stock sold by Gregory Lynds during past 3 months

Sale on 06/11/2026 5,537 shares for $281,030.99 Common stock sold by Gregory Lynds during past 3 months

Key Terms

Restricted Stock, Performance Shares, Securities To Be Sold, Securities Sold During The Past 3 Months

4 terms

Restricted Stock financial

"Common | 01/02/2012 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Performance Shares financial

"Common | 02/20/2019 | Performance Shares | Issuer"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is being planned by BJRI insider Gregory Lynds?

Gregory Lynds plans to sell up to 21,704 shares of BJRI common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with a proposed sale date of 08/06/2026 on NASDAQ.

What is the value associated with the 21,704 BJRI shares planned for sale?

The planned sale of 21,704 BJRI common shares is associated with an estimated value of $1,493,348.06, as indicated in the securities information section for the proposed Form 144 sale.

What prior BJRI stock sales has Gregory Lynds reported in the last three months?

Gregory Lynds reported BJRI common stock sales of 25,350 shares for $1,710,470.97 on 08/03/2026, 6,201 shares for $346,413.28 on 06/18/2026, and 5,537 shares for $281,030.99 on 06/11/2026.

What types of BJRI equity awards are the planned sale shares coming from?

The shares planned for sale come from 17,674 restricted stock shares granted on 01/02/2012 and 4,030 performance shares granted on 02/20/2019, both issued by the company.

Through which broker will the planned BJRI stock sale be executed?

The planned sale of 21,704 BJRI common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 04:17 PM Accepted by SEC EDGAR 08/06/2026 - 04:16 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001327770
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BJS RESTAURANTS, INC.
SEC File Number	000-21423
Address of Issuer	7755 Center Avenue, Suite 300 Huntington Beach CALIFORNIA 92647
Phone	(714) 500-2400
Name of Person for Whose Account the Securities are To Be Sold	GREGORY LYNDS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	21704	1493348.06	21273765	08/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/02/2012	Restricted Stock	Issuer			17674	01/02/2012	Not Applicable
Common	02/20/2019	Performance Shares	Issuer			4030	02/20/2019	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
GREGORY LYNDS 7755 Center Avenue, Suite 300 Huntington Beach CA 92647	Common	08/03/2026	25350	1710470.97
GREGORY LYNDS 7755 Center Avenue, Suite 300 Huntington Beach CA 92647	Common	06/18/2026	6201	346413.28
GREGORY LYNDS 7755 Center Avenue, Suite 300 Huntington Beach CA 92647	Common	06/11/2026	5537	281030.99

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock during the period of 01/02/2012 through 01/15/2023. The securities to be sold were acquired upon the vesting of performance shares during the period of 02/20/2019 through 02/15/2023.
Date of Notice	08/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gregory S Lynds
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)